At a glance
- Originator Pierrel
- Class Antihyperlipidaemics; Imidazoles
- Mechanism of Action Sterol O-acyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia
Most Recent Events
- 26 Feb 2008 Discontinued - Preclinical for Hyperlipidaemia in Sweden (unspecified route)
- 20 Jul 1998 No-Development-Reported for Hyperlipidaemia in Italy (Unknown route)
- 20 Jul 1998 No-Development-Reported for Hyperlipidaemia in Sweden (Unknown route)